Overview

Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy

Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether COX-2 inhibitor is effective in the treatment of primary hypertrophic osteoarthropathy
Phase:
Phase 3
Details
Lead Sponsor:
Peking Union Medical College Hospital
Treatments:
Cyclooxygenase 2 Inhibitors
Etoricoxib